Listed pet care firms post modest gains as sector stays resilient

Listed pet care companies posted a 3.16% gross return over the past 12 months in the Global Pet Care Index, according to GlobalPETS, a modest result that still points to resilience in a sector navigating broader market volatility and higher operating costs tied in part to elevated oil prices. The picture is mixed beneath the headline: other industry tracking has shown publicly traded pet companies continuing to grow revenue, but often lagging the wider equity market as post-pandemic growth normalizes and investors rotate toward faster-growing sectors. At the company level, H&H Group said its Pet Nutrition and Care segment grew at a high single-digit rate in fiscal 2025, with GlobalPETS reporting revenue of RMB 2.5 billion, driven largely by Zesty Paws, even as margins came under pressure. (globalpetindustry.com)

Why it matters: For veterinary professionals, the takeaway is that pet spending still looks comparatively defensive, especially in wellness, supplements, premium nutrition, and other recurring-care categories. But resilience at the sector level doesn’t mean every business is insulated: margin pressure, softer discretionary spending, and cost inflation can still shape product strategy, pricing, and partnership decisions across pet food, retail, and adjacent health businesses. That matters for clinics watching shifts in pet parent purchasing behavior, manufacturer investment, and the financial health of referral, nutrition, and preventive-care partners. (petfoodindustry.com)

What to watch: Watch upcoming earnings and trading updates for signs that margin pressure is easing, and whether supplements, preventive care, and premium nutrition continue to outperform more discretionary pet categories. (investing.com)